EPN 0.00% 2.4¢ epsilon healthcare limited

THC Global, page-119

  1. 3,040 Posts.
    lightbulb Created with Sketch. 572
    So AC8 have the licence, but can't start manufacturing till end of 2019 at best while THC have facility to manufacture, just no licence yet.....I know what I'd rather be holding. waiting for the ann that seeds in soil.

    IMO the quarterly will just show slightly improved revenue (coming of a low base) & increase in spending. Nothing there to excite a mouse.

    SP will take a pop when licence drops then the pull back, but serious money not going into any pot stocks on ASX, they are all drifting down &/or holding for short periods at best. EXL exception as there in the HEMP game in US market & making decent revenue. CAN had little run of late.

    Only when companies actually sell cannabis in whatever form to whoever or sell product in large quantities in an export stream will the SP move upwards. Actual profit near term & certainty of that will entice big money.
    Our Canadian acquisition will be an Ace on that one.

    It's all smoke n mirrors until then.
    https://hotcopper.com.au/data/attachments/1419/1419259-6fb47302df46b1c84f124e967d0d369a.jpg
 
watchlist Created with Sketch. Add EPN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.